About Our Lab
The Horvath Laboratory is a research group dedicated to improving the understanding of genetic neurological conditions, with a focus on mitochondrial and neurogenetic disease. The focus of this research is to identify key molecular disease mechanisms with the aim of developing treatments for patients with rare inherited neurological conditions, such as mitochondrial and Charcot–Marie–Tooth diseases.
ONGOING PROJECTS
mitochondrial disease; genetics; neuroscience; treatment development
Principal Investigator
Rita Horvath, MD, PhD
Rita Horvath, Clinical Director of Research at Addenbrooke’s Hospital, Cambridge, has spent over 25 years developing using genomics and biochemistry to diagnose rare, inherited neurological disorders. She has had significant translational impact throughout this time, enabling genetic counselling and prevention through precision genetic approaches. She has established extensive international collaborations, having impact in low to middle income countries, showing her clinical and genetic expertise is having impact way beyond patients in the NHS. She has developed two clinical services which span inherited neurological disorders, with a particular interest in mitochondrial disorders, ataxia and inherited neuropathies. Her commitment to developing new treatments in rare diseases is unwavering, most recently through new gene therapy approaches that she has established in Cambridge.
Postdoctoral Researchers
PhD Students
MPhil Students
Contact us
Rita Horvath, Director of Clinical Research
John Van Geest Cambridge Centre for Brain Repair The ED Adrian Building Forvie Site
Robinson Way, Cambridge CB2 0PY
Department of Clinical Neurosciences, University of Cambridge